Metabolic Syndrome and Erectile Dysfunction Among Obese Non-diabetic Subjects

Overview

Journal J Endocrinol Invest

Publisher Springer

Specialty Endocrinology

Date 2009 Jun 5

PMID 19494717

Citations 7

Authors

A Gatti

E Mandosi

M Fallarino

A Radicioni

E Morini

F Maiani

V Trischitta

A Lenzi

S Morano

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate whether MS is associated with erectile dysfunction (ED) among obese non diabetic individuals.

Methods: A cross-sectional study was carried out to examine the association between the cluster of abnormalities related to the MS and ED as evaluated by the International Index of Erectile Function (IIEF). Fifty consecutive obese [i.e. body mass index (BMI) > or =30 kg/m2], nondiabetic whites (age 42.1+/-11.3 yr, BMI 43.3+/-8.7 kg/m2) were recruited.

Results: The prevalence of MS as well as that of any MS component were not different between subjects with or without ED. Neither the prevalence of ED (34.3% vs 33.4%, p=0.6), nor IIEF score (21.5+/-3.9 vs 21.7+/-3.7, p=0.8), were different between patients with or without MS. IIEF was similar across subgroups of individuals stratified according to the number of MS components and was not related to HOMAIR index. Hypogonadism was observed in 30.8% and 28.1% individuals with and without MS (p=0.58). Testosterone and BMI levels were inversely related (r=-0.3, p=0.04).

Conclusion: Among obese non-diabetic individuals the risk of developing ED is independent of the presence of MS factors. Testosterone levels progressively decrease with increasing body weight.

Citing Articles

The conserved molecular mechanism of erectile dysfunction in type 2 diabetes rats and mice by cross-species transcriptomic comparisons.

Xiao M, Zeng H, Xu Y, Xu J, Tan X, Tang Y Sex Med. 2025; 13(1):qfaf007.

PMID: 40041301 PMC: 11879191. DOI: 10.1093/sexmed/qfaf007.

Association of insulin resistance surrogate indices and erectile dysfunction: a systematic review and meta-analysis.

Jalali S, Zareshahi N, Behnoush A, Azarboo A, Shirinezhad A, Hosseini S Reprod Biol Endocrinol. 2024; 22(1):148.

PMID: 39563412 PMC: 11574999. DOI: 10.1186/s12958-024-01317-4.

Current status and prospects of diabetes mellitus induced erectile dysfunction: A bibliometric and visualization study.

Zhang L, Bao B, Guo J, Qin Z, Huang H, Chen L Front Endocrinol (Lausanne). 2023; 14:1168744.

PMID: 37065751 PMC: 10100080. DOI: 10.3389/fendo.2023.1168744.

The role of microRNAs in erectile dysfunction: From pathogenesis to therapeutic potential.

Song J, Wang J, Liu K, Xu W, Sun T, Liu J Front Endocrinol (Lausanne). 2022; 13:1034043.

PMID: 36387873 PMC: 9640492. DOI: 10.3389/fendo.2022.1034043.

Erectile dysfunction as a marker of endocrine and glycemic disorders.

Mazzilli R, Zamponi V, Olana S, Mikovic N, Cimadomo D, Defeudis G J Endocrinol Invest. 2022; 45(8):1527-1534.

PMID: 35366160 PMC: 9270283. DOI: 10.1007/s40618-022-01788-5.

References

Cheng J, Ng E . Body mass index, physical activity and erectile dysfunction: an U-shaped relationship from population-based study. Int J Obes (Lond). 2007; 31(10):1571-8. DOI: 10.1038/sj.ijo.0803639. View

Bhasin S, Cunningham G, Hayes F, Matsumoto A, Snyder P, Swerdloff R . Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline. J Clin Endocrinol Metab. 2006; 91(6):1995-2010. DOI: 10.1210/jc.2005-2847. View

Demir T, Demir O, Kefi A, Comlekci A, Yesil S, Esen A . Prevalence of erectile dysfunction in patients with metabolic syndrome. Int J Urol. 2006; 13(4):385-8. DOI: 10.1111/j.1442-2042.2006.01310.x. View

Sand M, Fisher W, Rosen R, Heiman J, Eardley I . Erectile dysfunction and constructs of masculinity and quality of life in the multinational Men's Attitudes to Life Events and Sexuality (MALES) study. J Sex Med. 2008; 5(3):583-94. DOI: 10.1111/j.1743-6109.2007.00720.x. View

Althof S . Quality of life and erectile dysfunction. Urology. 2002; 59(6):803-10. DOI: 10.1016/s0090-4295(02)01606-0. View

. Standards of medical care in diabetes--2007. Diabetes Care. 2006; 30 Suppl 1:S4-S41. DOI: 10.2337/dc07-S004. View

Bacon C, Mittleman M, Kawachi I, Giovannucci E, Glasser D, Rimm E . Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann Intern Med. 2003; 139(3):161-8. DOI: 10.7326/0003-4819-139-3-200308050-00005. View

Makhsida N, Shah J, Yan G, Fisch H, Shabsigh R . Hypogonadism and metabolic syndrome: implications for testosterone therapy. J Urol. 2005; 174(3):827-34. DOI: 10.1097/01.ju.0000169490.78443.59. View

Rhoden E, Teloken C, Sogari P, Vargas Souto C . The use of the simplified International Index of Erectile Function (IIEF-5) as a diagnostic tool to study the prevalence of erectile dysfunction. Int J Impot Res. 2002; 14(4):245-50. DOI: 10.1038/sj.ijir.3900859. View

10.

Corona G, Mannucci E, Petrone L, Schulman C, Balercia G, Fisher A . A comparison of NCEP-ATPIII and IDF metabolic syndrome definitions with relation to metabolic syndrome-associated sexual dysfunction. J Sex Med. 2007; 4(3):789-796. DOI: 10.1111/j.1743-6109.2007.00498.x. View

11.

Matthews D, Hosker J, Rudenski A, Naylor B, Treacher D, Turner R . Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28(7):412-9. DOI: 10.1007/BF00280883. View

12.

Selvin E, Burnett A, Platz E . Prevalence and risk factors for erectile dysfunction in the US. Am J Med. 2007; 120(2):151-7. DOI: 10.1016/j.amjmed.2006.06.010. View

13.

Esposito K, Giugliano F, Di Palo C, Giugliano G, Marfella R, DAndrea F . Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA. 2004; 291(24):2978-84. DOI: 10.1001/jama.291.24.2978. View

14.

Kupelian V, Page S, Araujo A, Travison T, Bremner W, McKinlay J . Low sex hormone-binding globulin, total testosterone, and symptomatic androgen deficiency are associated with development of the metabolic syndrome in nonobese men. J Clin Endocrinol Metab. 2006; 91(3):843-50. DOI: 10.1210/jc.2005-1326. View

15.

Bansal T, Guay A, Jacobson J, Woods B, Nesto R . Incidence of metabolic syndrome and insulin resistance in a population with organic erectile dysfunction. J Sex Med. 2006; 2(1):96-103. DOI: 10.1111/j.1743-6109.2005.20120.x. View

16.

Litwin M, Nied R, Dhanani N . Health-related quality of life in men with erectile dysfunction. J Gen Intern Med. 1998; 13(3):159-66. PMC: 1496922. DOI: 10.1046/j.1525-1497.1998.00050.x. View

17.

Fung M, Bettencourt R, Barrett-Connor E . Heart disease risk factors predict erectile dysfunction 25 years later: the Rancho Bernardo Study. J Am Coll Cardiol. 2004; 43(8):1405-11. DOI: 10.1016/j.jacc.2003.11.041. View

18.

Derby C, Mohr B, Goldstein I, Feldman H, Johannes C, McKinlay J . Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk?. Urology. 2000; 56(2):302-6. DOI: 10.1016/s0090-4295(00)00614-2. View

19.

Osuna J, Gomez-Perez R, Arata-Bellabarba G, Villaroel V . Relationship between BMI, total testosterone, sex hormone-binding-globulin, leptin, insulin and insulin resistance in obese men. Arch Androl. 2006; 52(5):355-61. DOI: 10.1080/01485010600692017. View

20.

Hammoud A, Gibson M, Peterson C, Hamilton B, Carrell D . Obesity and male reproductive potential. J Androl. 2006; 27(5):619-26. DOI: 10.2164/jandrol.106.000125. View